SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TGV Sraac touches roof on getting nod to make further investment of Rs 10 crore in BBPL

20 May 2022 Evaluate

TGV Sraac is locked its upper circuit limit at Rs. 93.65, up by 4.45 points or 4.99% from its previous closing of Rs. 89.20 on the BSE.

The scrip opened at Rs. 93.65 and has touched a high and low of Rs. 93.65 and Rs. 92.90 respectively. So far 754088 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 109.60 on 29-Apr-2022 and a 52 week low of Rs. 29.85 on 18-Jun-2021.

Last one week high and low of the scrip stood at Rs. 93.65 and Rs. 75.00 respectively. The current market cap of the company is Rs. 1002.90 crore.

The promoters holding in the company stood at 63.18%, while Institutions and Non-Institutions held 0.02% and 36.80% respectively.

TGV Sraac has received an approval for making further investment of upto Rs 10 crore in Brilliant Bio Pharma (BBPL). The company intends to enter into the field of pharma in future for forward integration and value addition. By partnering with the already established BBPL will help the company to understand and make a step to focus on the pharma for future. The Board of Directors in their meeting held on May 19, 2022 has given approval to the same.

TGV Sraac (Formerly Known as Sree Rayalaseema Alkalies and Allied Chemicals) is engaged in the Business of leading producer of Chlor-Alkali products, Chloromethane and also manufactures Castor Derivatives and Fatty Acids.

TGV SRACC Share Price

113.17 2.05 (1.84%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×